Previous 10 | Next 10 |
home / stock / mnkkq / mnkkq news
Mallinckrodt Announces Publication of Real-World Data from Retrospective Study on the Investigational Use of Inhaled Nitric Oxide in Hospitalized COVID-19 Patients PR Newswire – Medical chart review study, published in Drugs in Context , evaluated the rea...
Retrospective Study on Real-World Treatment Patterns and Outcomes of Acthar® Gel (Repository Corticotropin Injection) in Patients with Refractory Rheumatoid Arthritis Published in Drugs in Context PR Newswire – Electronic medical chart analysis showed Acthar ...
Silence Therapeutics plc (NASDAQ:SLN) will receive a $3M research milestone payment from Mallinckrodt (OTCPK:MNKKQ) as the companies announced filing of a clinical trial application (CTA) for SLN501 targeting complement-mediated diseases. In July 2019, Silence and Mallinckrodt began...
Mallinckrodt (OTCPK:MNKKQ +4.2%) has agreed to pay the U.S. Department of Justice $260M to settle allegations it violated the False Claims Act. More specifically, DoJ alleges the company underpaid drug rebates for its Achtar gel and used a foundation to pay illegal co-pay subsidies violating ...
The former NYSE-listed company has gone through a wild twist of events since its heyday on the Exchange. Mallinckrodt ( OTC: MNKKQ ) and its subsidiaries went into bankruptcy in 2020. It pushed forward with a plan to reorganize going as far as gaining support with its lenders holding ov...
The U.S. FDA has issued a Complete Response Letter to Mallinckrodt (MNK) for terlipressin for the kidney ailment hepatorenal syndrome. The company said that in the last two weeks, it became necessary to identify a new packaging and labeling manufacturing facility. That meant an inspectio...
Mallinckrodt Provides a Regulatory Update on Terlipressin PR Newswire DUBLIN , Feb. 22, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued...
Mallinckrodt Plan of Reorganization Confirmed by U.S. Court PR Newswire DUBLIN , Feb. 3, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ) (" Mallinckrodt " or the "Company") today announced that its Plan of Reorganization (the "Plan") has been conf...
Mallinckrodt Earns Top Marks Again in Human Rights Campaign Foundation's 2022 Corporate Equality Index For the sixth straight year, Mallinckrodt earns a perfect 100 on the Human Rights Campaign Foundation's annual assessment of LGBTQ+ workplace equality PR Newswire ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nutriband (NASDAQ: NTRB ) stock is soaring 170% in mid-morning trading after the company announced today that it was granted a patent for “abuse deterrent” technology, called Aversa. The patent was gra...
News, Short Squeeze, Breakout and More Instantly...
Mallinckrodt plc Company Name:
MNKKQ Stock Symbol:
OTCMKTS Market:
MALLINCKRODT TO REPORT EARNINGS RESULTS FOR SECOND QUARTER 2022 AND PROVIDE BUSINESS UPDATE PR Newswire DUBLIN , Aug. 3, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, announced today that it wil...
Mallinckrodt Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Financial Flexibility PR Newswire Appoints Sigurdur Olafsson as President and Chief Executive Officer DUBLIN, Ireland , June 16, 2022 /PRNewswire/ -- Mallinckr...
Mallinckrodt Announces Resubmission of Terlipressin to the FDA for the Treatment of Hepatorenal Syndrome PR Newswire DUBLIN , June 13, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced the ...